Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis

This study has been completed.
Information provided by:
Tibotec BVBA Identifier:
First received: August 30, 2007
Last updated: August 14, 2012
Last verified: August 2012